Lupus nephritis may affect life expectancy if it is not treated timely and the pathologic manifestations are severe, so timely treatment is needed.
SLE is a multifactorial autoimmune disease, which is characterized by the involvement of multiple systems throughout the body. About 50% of SLE patients have kidney involvement, which is called “lupus nephritis”. Lupus nephritis is a common and serious complication of SLE and has a significant impact on the long-term prognosis of patients.
There are 6 types of lupus nephritis, and if the pathology is severe, untimely treatment may affect life expectancy. Lupus nephritis treatment drugs include hormones (prednisone, methylprednisolone), immunosuppressants (cyclophosphamide, mertiomacrolide, etc.).
Lupus nephritis is a chronic kidney disease, and its supportive treatment should follow the principle of “integration”, such as strict control of hypertension, hyperlipidemia, and adjustment of calcium and phosphorus metabolism.
If you are diagnosed with lupus nephritis, you should go to the hospital in time and actively cooperate with the doctor to avoid delaying your condition.